1. Sanofi Board Says CEO Succession Not on Meeting Agenda

    Sanofi Board Says CEO Succession Not on Meeting Agenda

    Sanofi's board of directors said Chief Executive Chris Viehbacher's succession was not on the agenda of a meeting scheduled for later on Monday, after Les Echos newspaper reported that the board may address the subject. The newspaper had said that the meeting, ahead of third-quarter results on Tuesday, followed concerns among certain directors that Viehbacher was running the French ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content

    1. Like any board of a publicly traded company, from time to time Sanofi's board meets in non-executive sessions to discuss a wide range of issues.
    2. Such a move would come as a surprise and would be seen as highly negative by the market as Mr Viehbacher has a great track record since he is at the helm.
  3. Topics Mentioned